The Danish drugmaker announced plans to streamline its operations in response to an increasingly competitive and consumer-focused market.
In order to enhance agility and efficiency, the company is implementing strategic changes aimed at improving its operational framework.
This move reflects the broader trends within the pharmaceutical industry as companies adapt to evolving market demands.